These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 20359589)

  • 1. Acute coronary syndrome: emerging tools for diagnosis and risk assessment.
    Scirica BM
    J Am Coll Cardiol; 2010 Apr; 55(14):1403-15. PubMed ID: 20359589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Troponin T or troponin I or CK-MB (or none?).
    Collinson PO
    Eur Heart J; 1998 Nov; 19 Suppl N():N16-24. PubMed ID: 9857934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging cardiac markers in coronary disease: role of brain natriuretic peptide and other biomarkers.
    Palazzuoli A; Iovine F; Gallotta M; Nuti R
    Minerva Cardioangiol; 2007 Aug; 55(4):491-6. PubMed ID: 17653025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth differentiation factor 15 for risk stratification and selection of an invasive treatment strategy in non ST-elevation acute coronary syndrome.
    Wollert KC; Kempf T; Lagerqvist B; Lindahl B; Olofsson S; Allhoff T; Peter T; Siegbahn A; Venge P; Drexler H; Wallentin L
    Circulation; 2007 Oct; 116(14):1540-8. PubMed ID: 17848615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-terminal B-type natriuretic peptide assessment provides incremental prognostic information in patients with acute coronary syndromes and normal troponin T values upon admission.
    Weber M; Bazzino O; Navarro Estrada JL; Fuselli JJ; Botto F; Perez de Arenaza D; Möllmann H; Nef HN; Elsässer A; Hamm CW
    J Am Coll Cardiol; 2008 Mar; 51(12):1188-95. PubMed ID: 18355657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis of acute coronary syndrome.
    Achar SA; Kundu S; Norcross WA
    Am Fam Physician; 2005 Jul; 72(1):119-26. PubMed ID: 16035692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clinical dilemma of positive results of high-sensitive troponin assays.
    Lippi G; Montagnana M; Guidi GC
    Am J Cardiol; 2009 May; 103(9):1332. PubMed ID: 19406287
    [No Abstract]   [Full Text] [Related]  

  • 8. The emerging role of highly sensitive troponin in the evaluation of acute coronary syndrome.
    Mohammed AA; Januzzi JL
    Compr Ther; 2009; 35(3-4):167-76. PubMed ID: 20043613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical correlation of multiple biomarkers for risk assessment in patients with acute coronary syndrome.
    Narain VS; Gupta N; Sethi R; Puri A; Dwivedi SK; Saran RK; Puri VK
    Indian Heart J; 2008; 60(6):536-42. PubMed ID: 19276492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical applications of highly sensitive troponin assays.
    Mohammed AA; Januzzi JL
    Cardiol Rev; 2010; 18(1):12-9. PubMed ID: 20010334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heart-type fatty acid binding protein--a reliable marker of myocardial necrosis in a heterogeneous group of patients with acute coronary syndrome without persistent ST elevation.
    Figiel Ł; Kasprzak JD; Peruga J; Lipiec P; Drozdz J; Krzemińska-Pakuła M; Smigielski J
    Kardiol Pol; 2008 Mar; 66(3):253-9, discussion 260-1. PubMed ID: 18393112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Creatine kinase isoenzyme MB mass, cardiac troponin T, and myosin light chain isotype 1 as serological markers of myocardial injury and their prognostic importance in acute coronary syndrome.
    Ravkilde J
    Dan Med Bull; 1998 Feb; 45(1):34-50. PubMed ID: 9504265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The report card on growth differentiation factor 15: consistent marks but not yet ready for promotion.
    Rohatgi A; de Lemos JA
    Circ Cardiovasc Genet; 2009 Jun; 2(3):209-11. PubMed ID: 20031588
    [No Abstract]   [Full Text] [Related]  

  • 14. [Redefinition of myocardial infarction--relevance of biomarkers].
    Weber M; Hamm C
    Herz; 2008 Mar; 33(2):115-21. PubMed ID: 18344030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multimarker risk stratification approach to non-ST elevation acute coronary syndrome: implications of troponin T, CRP, NT pro-BNP and fibrin D-dimer levels.
    Tello-Montoliu A; Marín F; Roldán V; Mainar L; López MT; Sogorb F; Vicente V; Lip GY
    J Intern Med; 2007 Dec; 262(6):651-8. PubMed ID: 17986200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic implications of the use of cardiac markers in acute coronary syndromes.
    Lindahl B
    Scand J Clin Lab Invest Suppl; 1999; 230():43-9. PubMed ID: 10389201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac biomarkers - the old and the new: a review.
    Singh V; Martinezclark P; Pascual M; Shaw ES; O'Neill WW
    Coron Artery Dis; 2010 Jun; 21(4):244-56. PubMed ID: 20351549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The skinny on fatty acid-binding protein.
    de Lemos JA; O'Donoghue M
    J Am Coll Cardiol; 2007 Nov; 50(21):2068-70. PubMed ID: 18021875
    [No Abstract]   [Full Text] [Related]  

  • 19. [Acute coronary syndrome and inflammation. Biomarkers for diagnostics and risk stratification].
    Trepels T; Zeiher AM; Fichtlscherer S
    Herz; 2004 Dec; 29(8):769-76. PubMed ID: 15599673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Leading symptoms of chest pain in the emergency room. Using cardiac markers for risk stratification].
    Walter S; Carlsson J; Cuneo A; Tebbe U
    Dtsch Med Wochenschr; 2001 Jul; 126(27):771-8. PubMed ID: 11486476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.